메뉴 건너뛰기




Volumn 9, Issue 1, 2007, Pages 29-45

Neuropsychiatric consequences of cardiovascular medications

Author keywords

Adverse effect; Cardiovascular agent; Delirium; Fatigue; Mood disorder; Neurologic manifestation; Psychotic disorder

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPRENORPHINE; CAPTOPRIL; CARDIOVASCULAR AGENT; CERANAPRIL; CLONIDINE; DILTIAZEM; DISOPYRAMIDE; DOXAZOSIN; FLECAINIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; ISOSORBIDE DINITRATE; LITHIUM; METHYLDOPA; METOPROLOL; NICARDIPINE; NITRATE; PINDOLOL; PLACEBO; PRAZOSIN; PROCAINAMIDE; PROPRANOLOL DERIVATIVE; RESERPINE; SEROTONIN UPTAKE INHIBITOR; UNINDEXED DRUG; VALSARTAN; VERAPAMIL;

EID: 34247275851     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (89)

References (290)
  • 1
    • 0035944828 scopus 로고    scopus 로고
    • Relation between depression after coronary artery bypass surgery and 12-month outcome: A prospective study
    • Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet. 2001;358:1766-1771.
    • (2001) Lancet , vol.358 , pp. 1766-1771
    • Connerney, I.1    Shapiro, P.A.2    McLaughlin, J.S.3    Bagiella, E.4    Sloan, R.P.5
  • 2
    • 33644585361 scopus 로고    scopus 로고
    • Depression and anxiety in heart failure
    • Konstam V, Moser DK, De Jong MJ. Depression and anxiety in heart failure. J Card Fail. 2005;11:455-463.
    • (2005) J Card Fail , vol.11 , pp. 455-463
    • Konstam, V.1    Moser, D.K.2    De Jong, M.J.3
  • 3
    • 9244225620 scopus 로고    scopus 로고
    • Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis
    • van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66:814-822.
    • (2004) Psychosom Med , vol.66 , pp. 814-822
    • van Melle, J.P.1    de Jonge, P.2    Spijkerman, T.A.3
  • 4
    • 0029801617 scopus 로고    scopus 로고
    • Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events?
    • Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med. 1996;58:395-401.
    • (1996) Psychosom Med , vol.58 , pp. 395-401
    • Moser, D.K.1    Dracup, K.2
  • 5
    • 0029366801 scopus 로고
    • The impact of negative emotions on prognosis following myocardial infarction: Is it more than depression?
    • Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol. 1995;14:388-398.
    • (1995) Health Psychol , vol.14 , pp. 388-398
    • Frasure-Smith, N.1    Lesperance, F.2    Talajic, M.3
  • 6
    • 28444493009 scopus 로고    scopus 로고
    • Delirium in the postoperative cardiac patient: A review
    • Sockalingam S, Parekh N, Bogoch II, et al. Delirium in the postoperative cardiac patient: a review. J Card Surg. 2005;20:560-567.
    • (2005) J Card Surg , vol.20 , pp. 560-567
    • Sockalingam, S.1    Parekh, N.2    Bogoch II3
  • 7
    • 0025305110 scopus 로고
    • Propranolol and depression: Evidence from the antihypertensive trials
    • Patten SB. Propranolol and depression: evidence from the antihypertensive trials. Can J Psychiatry. 1990;35:257-259.
    • (1990) Can J Psychiatry , vol.35 , pp. 257-259
    • Patten, S.B.1
  • 8
    • 0021018314 scopus 로고
    • Propranolol-induced depression: Mechanism and management
    • Oppenheim G. Propranolol-induced depression: mechanism and management. Aust N Z J Psychiatry. 1983;17:400-402.
    • (1983) Aust N Z J Psychiatry , vol.17 , pp. 400-402
    • Oppenheim, G.1
  • 9
    • 0019967022 scopus 로고
    • Substitution of atenolol for propranolol in a case of propranolol-related depression
    • McNeil GN, Shaw PK, Dock DS. Substitution of atenolol for propranolol in a case of propranolol-related depression. Am J Psychiatry. 1982;139:1187-1188.
    • (1982) Am J Psychiatry , vol.139 , pp. 1187-1188
    • McNeil, G.N.1    Shaw, P.K.2    Dock, D.S.3
  • 10
    • 0021917486 scopus 로고
    • Propranolol and depression revisited: Three cases and a review
    • Pollack MH, Rosenbaum JF, Cassem NH. Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis. 1985;173:118-119.
    • (1985) J Nerv Ment Dis , vol.173 , pp. 118-119
    • Pollack, M.H.1    Rosenbaum, J.F.2    Cassem, N.H.3
  • 11
    • 84965269930 scopus 로고
    • Propanolol-induced depression
    • Fitzgerald JD. Propanolol-induced depression. BMJ. 1967;2:372-373.
    • (1967) BMJ , vol.2 , pp. 372-373
    • Fitzgerald, J.D.1
  • 13
    • 0029821351 scopus 로고    scopus 로고
    • Evidence of depression provoked by cardiovascular medication: A prescription sequence symmetry analysis
    • Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology. 1996;7:478-484.
    • (1996) Epidemiology , vol.7 , pp. 478-484
    • Hallas, J.1
  • 14
    • 0025350611 scopus 로고
    • Antihypertensive therapy and quality of life: A comparison of atenolol, captopril, enalapril and propranolol
    • Steiner SS, Friedhoff AJ, Wilson BL, Wecker JR, Santo JP. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. J Hum Hypertens. 1990;4:217-225.
    • (1990) J Hum Hypertens , vol.4 , pp. 217-225
    • Steiner, S.S.1    Friedhoff, A.J.2    Wilson, B.L.3    Wecker, J.R.4    Santo, J.P.5
  • 15
    • 0342858928 scopus 로고    scopus 로고
    • The effects of propranolol on cognitive function and quality of life: A randomized trial among patients with diastolic hypertension (no increase in depression at 12 months, 312 patients)
    • Perez-Stable EJ, Halliday R, Gardiner PS, et al. The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension (no increase in depression at 12 months, 312 patients). Am J Med. 2000;108:359-365.
    • (2000) Am J Med , vol.108 , pp. 359-365
    • Perez-Stable, E.J.1    Halliday, R.2    Gardiner, P.S.3
  • 16
    • 0026534403 scopus 로고
    • Beta-blockers and depression. Evidence against an association
    • Bright RA, Everitt DE. Beta-blockers and depression. Evidence against an association. JAMA. 1992;267:1783-1787.
    • (1992) JAMA , vol.267 , pp. 1783-1787
    • Bright, R.A.1    Everitt, D.E.2
  • 17
    • 0021436759 scopus 로고
    • Propranolol and depression: A reevaluation based on a pilot clinical trial
    • Stoudemire A, Brown JT, Harris RT, et al. Propranolol and depression: a reevaluation based on a pilot clinical trial. Psychiatr Med. 1984;2:211-218.
    • (1984) Psychiatr Med , vol.2 , pp. 211-218
    • Stoudemire, A.1    Brown, J.T.2    Harris, R.T.3
  • 18
    • 0023614091 scopus 로고
    • Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications
    • Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications. Am J Med. 1987;83:223-226.
    • (1987) Am J Med , vol.83 , pp. 223-226
    • Carney, R.M.1    Rich, M.W.2    teVelde, A.3    Saini, J.4    Clark, K.5    Freedland, K.E.6
  • 21
    • 0037125378 scopus 로고    scopus 로고
    • Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction
    • Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351-357.
    • (2002) JAMA , vol.288 , pp. 351-357
    • Ko, D.T.1    Hebert, P.R.2    Coffey, C.S.3    Sedrakyan, A.4    Curtis, J.P.5    Krumholz, H.M.6
  • 22
    • 0024523868 scopus 로고
    • Neuropsychological side effects of beta-blockers
    • Dimsdale JE, Newton RP, Joist T. Neuropsychological side effects of beta-blockers. Arch Intern Med. 1989;149:514-525.
    • (1989) Arch Intern Med , vol.149 , pp. 514-525
    • Dimsdale, J.E.1    Newton, R.P.2    Joist, T.3
  • 23
    • 0020416916 scopus 로고
    • Psychiatric side effects of antihypertensive drugs other than reserpine
    • Paykel ES, Fleminger R, Watson JP. Psychiatric side effects of antihypertensive drugs other than reserpine. J Clin Psychopharmacol. 1982;2:14-39.
    • (1982) J Clin Psychopharmacol , vol.2 , pp. 14-39
    • Paykel, E.S.1    Fleminger, R.2    Watson, J.P.3
  • 24
    • 34247183871 scopus 로고    scopus 로고
    • atenolol) prescribing information
    • Wilmington, Del: AstraZeneca;
    • Tenormin (atenolol) prescribing information. Wilmington, Del: AstraZeneca; 2005.
    • (2005)
    • Tenormin1
  • 25
    • 0026576464 scopus 로고
    • Cognitive effects of beta-blockers
    • Dimsdale JE, Newton RP. Cognitive effects of beta-blockers. J Psychosom Res. 1992;36:229-236.
    • (1992) J Psychosom Res , vol.36 , pp. 229-236
    • Dimsdale, J.E.1    Newton, R.P.2
  • 26
    • 0024523868 scopus 로고
    • Neuropsychological side effects of beta-blockers
    • Dimsdale JE, Newton RP, Joist T. Neuropsychological side effects of beta-blockers. Arch Intern Med. 1989;149:514-525.
    • (1989) Arch Intern Med , vol.149 , pp. 514-525
    • Dimsdale, J.E.1    Newton, R.P.2    Joist, T.3
  • 27
    • 0029103414 scopus 로고
    • Toxic psychosis: An unusual presentation of propranolol intoxication
    • Love JN, Handler JA. Toxic psychosis: an unusual presentation of propranolol intoxication. Am J Emerg Med. 1995;13:536-537.
    • (1995) Am J Emerg Med , vol.13 , pp. 536-537
    • Love, J.N.1    Handler, J.A.2
  • 29
    • 0021964165 scopus 로고
    • Propranolol-induced depression and psychosis
    • Parker WA. Propranolol-induced depression and psychosis. Clin Pharmacol. 1985;4:214-218.
    • (1985) Clin Pharmacol , vol.4 , pp. 214-218
    • Parker, W.A.1
  • 30
    • 0020840949 scopus 로고
    • Acute psychotic behavior associated with atenolol
    • Viadero JJ, Wong SH, White WB. Acute psychotic behavior associated with atenolol. Am J Psychiatry. 1983;140:1382.
    • (1983) Am J Psychiatry , vol.140 , pp. 1382
    • Viadero, J.J.1    Wong, S.H.2    White, W.B.3
  • 32
    • 33748433966 scopus 로고    scopus 로고
    • Clinical practice. Social anxiety disorder
    • Schneier FR. Clinical practice. Social anxiety disorder. N Engl J Med. 2006;355:1029-1036.
    • (2006) N Engl J Med , vol.355 , pp. 1029-1036
    • Schneier, F.R.1
  • 33
    • 0037109802 scopus 로고    scopus 로고
    • What to do when SSRIs fail: Eight strategies for optimizing treatment of panic disorder
    • Zamorski MA, Albucher RC. What to do when SSRIs fail: eight strategies for optimizing treatment of panic disorder. Am Fam Physician. 2002;66:1477-1484.
    • (2002) Am Fam Physician , vol.66 , pp. 1477-1484
    • Zamorski, M.A.1    Albucher, R.C.2
  • 34
    • 0033829587 scopus 로고    scopus 로고
    • Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial
    • Hirschmann S, Dannon PN, Iancu I, Dolberg OT, Zohar J, Grunhaus L. Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2000;20:556-559.
    • (2000) J Clin Psychopharmacol , vol.20 , pp. 556-559
    • Hirschmann, S.1    Dannon, P.N.2    Iancu, I.3    Dolberg, O.T.4    Zohar, J.5    Grunhaus, L.6
  • 35
    • 0034004169 scopus 로고    scopus 로고
    • Pindolol augmentation in treatment-resistant obsessive compulsive disorder: A double-blind placebo controlled trial
    • Dannon PN, Sasson Y, Hirschmann S, Iancu I, Grunhaus LJ, Zohar J. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial. Eur Neuropsychopharmacol. 2000;10:165-169.
    • (2000) Eur Neuropsychopharmacol , vol.10 , pp. 165-169
    • Dannon, P.N.1    Sasson, Y.2    Hirschmann, S.3    Iancu, I.4    Grunhaus, L.J.5    Zohar, J.6
  • 36
    • 0142188601 scopus 로고    scopus 로고
    • Vaiva G, Ducrocq F, Jezequel K, et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry. 2003;54:947-949. Erratum in: Biol Psychiatry. 2003;54:1471.
    • Vaiva G, Ducrocq F, Jezequel K, et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry. 2003;54:947-949. Erratum in: Biol Psychiatry. 2003;54:1471.
  • 37
    • 0037081437 scopus 로고    scopus 로고
    • Pilot study of secondary prevention of posttraumatic stress disorder with propranolol
    • Pitman RK, Sanders KM, Zusman RM, et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002;51:189-192.
    • (2002) Biol Psychiatry , vol.51 , pp. 189-192
    • Pitman, R.K.1    Sanders, K.M.2    Zusman, R.M.3
  • 38
    • 0037268429 scopus 로고    scopus 로고
    • Pharmacological management for agitation and aggression in people with acquired brain injury
    • CD003299
    • Fleminger S, Greenwood RJ, Oliver DL. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst Rev. 2003;1:CD003299.
    • (2003) Cochrane Database Syst Rev , pp. 1
    • Fleminger, S.1    Greenwood, R.J.2    Oliver, D.L.3
  • 39
    • 0028928734 scopus 로고
    • Beta-blockers and the treatment of aggression
    • Haspel T. Beta-blockers and the treatment of aggression. Harv Rev Psychiatry. 1995;2:274-281.
    • (1995) Harv Rev Psychiatry , vol.2 , pp. 274-281
    • Haspel, T.1
  • 40
    • 0031005348 scopus 로고    scopus 로고
    • Psychopharmacologic treatment of pathologic aggression
    • Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am. 1997;20:427-451.
    • (1997) Psychiatr Clin North Am , vol.20 , pp. 427-451
    • Fava, M.1
  • 41
    • 16844373488 scopus 로고    scopus 로고
    • Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: A placebo-controlled study
    • Peskind ER, Tsuang DW, Bonner LT, et al. Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study. Alzheimer Dis Assoc Disord. 2005;19:23-28.
    • (2005) Alzheimer Dis Assoc Disord , vol.19 , pp. 23-28
    • Peskind, E.R.1    Tsuang, D.W.2    Bonner, L.T.3
  • 42
    • 14044274779 scopus 로고    scopus 로고
    • Neuroleptic-induced movement disorders: An overview
    • Sachdev PS. Neuroleptic-induced movement disorders: an overview. Psychiatr Clin North Am. 2005;28:255-274.
    • (2005) Psychiatr Clin North Am , vol.28 , pp. 255-274
    • Sachdev, P.S.1
  • 43
    • 0024591499 scopus 로고
    • The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial
    • Horwitz RI, Gottlieb LD, Kraus ML. The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial. Arch Intern Med. 1989;149:1089-1093.
    • (1989) Arch Intern Med , vol.149 , pp. 1089-1093
    • Horwitz, R.I.1    Gottlieb, L.D.2    Kraus, M.L.3
  • 44
    • 0022346653 scopus 로고
    • Randomized clinical trial of atenolol in patients with alcohol withdrawal
    • Kraus ML, Gottlieb LD, Horwitz RI, Anscher M. Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med. 1985;313:905-909.
    • (1985) N Engl J Med , vol.313 , pp. 905-909
    • Kraus, M.L.1    Gottlieb, L.D.2    Horwitz, R.I.3    Anscher, M.4
  • 45
    • 1542404781 scopus 로고    scopus 로고
    • Effectiveness of pindolol plus serotonin uptake inhibitors in depression: A meta-analysis of early and late outcomes from randomised controlled trials
    • Ballesteros J, Callado LF. Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. J Affect Disord. 2004;79:137-147.
    • (2004) J Affect Disord , vol.79 , pp. 137-147
    • Ballesteros, J.1    Callado, L.F.2
  • 46
    • 0024549875 scopus 로고
    • Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs
    • Cushman DW, Wang FL, Fung WC, Harvey CM, DeForrest JM. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. Am J Hypertens. 1989;2:294-306.
    • (1989) Am J Hypertens , vol.2 , pp. 294-306
    • Cushman, D.W.1    Wang, F.L.2    Fung, W.C.3    Harvey, C.M.4    DeForrest, J.M.5
  • 47
    • 0037344546 scopus 로고    scopus 로고
    • Neuropsychiatric effects of cardiovascular drug therapy
    • Keller S, Frishman WH. Neuropsychiatric effects of cardiovascular drug therapy. Cardiol Rev. 2003;11:73-93.
    • (2003) Cardiol Rev , vol.11 , pp. 73-93
    • Keller, S.1    Frishman, W.H.2
  • 49
    • 0024564810 scopus 로고
    • Captopril treatment of major depression with serial measurements of blood Cortisol concentrations
    • Germain L, Chouinard G. Captopril treatment of major depression with serial measurements of blood Cortisol concentrations. Biol Psychiatry. 1989;25:489-493.
    • (1989) Biol Psychiatry , vol.25 , pp. 489-493
    • Germain, L.1    Chouinard, G.2
  • 50
    • 0023847794 scopus 로고
    • Treatment of recurrent unipolar major depression with captopril
    • Germain L, Chouinard G. Treatment of recurrent unipolar major depression with captopril. Biol Psychiatry. 1988;23:637-641.
    • (1988) Biol Psychiatry , vol.23 , pp. 637-641
    • Germain, L.1    Chouinard, G.2
  • 51
    • 0022655123 scopus 로고
    • The effects of antihypertensive therapy on the quality of life
    • Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986;314:1657-1664.
    • (1986) N Engl J Med , vol.314 , pp. 1657-1664
    • Croog, S.H.1    Levine, S.2    Testa, M.A.3
  • 53
    • 0025891553 scopus 로고
    • Manic symptoms associated with the use of captopril
    • Patten SB, Brager N, Sanders S. Manic symptoms associated with the use of captopril. Can J Psychiatry. 1991;36:314-315.
    • (1991) Can J Psychiatry , vol.36 , pp. 314-315
    • Patten, S.B.1    Brager, N.2    Sanders, S.3
  • 54
    • 0021869512 scopus 로고
    • Bipolar affective symptoms associated with use of captopril and abrupt withdrawal of pargyline and propranolol
    • McMahon T. Bipolar affective symptoms associated with use of captopril and abrupt withdrawal of pargyline and propranolol. Am J Psychiatry. 1985;142:759-760.
    • (1985) Am J Psychiatry , vol.142 , pp. 759-760
    • McMahon, T.1
  • 55
    • 0029117955 scopus 로고
    • Mania secondary to lisinopril therapy
    • Skop BP, Masterson BJ. Mania secondary to lisinopril therapy. Psychosomatics. 1995;36:508-509.
    • (1995) Psychosomatics , vol.36 , pp. 508-509
    • Skop, B.P.1    Masterson, B.J.2
  • 56
    • 0025751707 scopus 로고
    • The use of captopril in treatment-resistant depression: An open trial
    • Vuckovic A, Cohen BM, Zubenko GS. The use of captopril in treatment-resistant depression: an open trial. J Clin Psychopharmacol. 1991;11:395-396.
    • (1991) J Clin Psychopharmacol , vol.11 , pp. 395-396
    • Vuckovic, A.1    Cohen, B.M.2    Zubenko, G.S.3
  • 58
    • 0025758867 scopus 로고
    • Enalapril-induced acute psychosis
    • Ahmad S. Enalapril-induced acute psychosis. DICP. 1991;25:558-559.
    • (1991) DICP , vol.25 , pp. 558-559
    • Ahmad, S.1
  • 59
    • 0000989030 scopus 로고
    • Reversal of captopril-induced psychosis with naloxone
    • Gillman MA, Sandyk R. Reversal of captopril-induced psychosis with naloxone. Am J Psychiatry. 1985;142:270.
    • (1985) Am J Psychiatry , vol.142 , pp. 270
    • Gillman, M.A.1    Sandyk, R.2
  • 60
    • 0032943339 scopus 로고    scopus 로고
    • Effects of captopril and enalapril on electroencephalogram and cognitive performance in healthy volunteers
    • Ebert U, Kirch W. Effects of captopril and enalapril on electroencephalogram and cognitive performance in healthy volunteers. Eur J Clin Pharmacol. 1999;55:255-257.
    • (1999) Eur J Clin Pharmacol , vol.55 , pp. 255-257
    • Ebert, U.1    Kirch, W.2
  • 61
    • 0025184176 scopus 로고
    • Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood
    • Currie D, Lewis RV, McDevitt DG, Nicholson AN, Wright NA. Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood. Br J Clin Pharmacol. 1990;30:527-536.
    • (1990) Br J Clin Pharmacol , vol.30 , pp. 527-536
    • Currie, D.1    Lewis, R.V.2    McDevitt, D.G.3    Nicholson, A.N.4    Wright, N.A.5
  • 62
    • 0027327689 scopus 로고
    • A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer disease
    • Sudilovsky A, Cutler NR, Sramek JJ, et al. A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer disease. Alzheimer Dis Assoc Disord. 1993;7:105-111.
    • (1993) Alzheimer Dis Assoc Disord , vol.7 , pp. 105-111
    • Sudilovsky, A.1    Cutler, N.R.2    Sramek, J.J.3
  • 63
    • 34247243802 scopus 로고    scopus 로고
    • Capoten (captopril) prescribing information. Princeton, NJ: Brisol-Myers Squibb; 1996.
    • Capoten (captopril) prescribing information. Princeton, NJ: Brisol-Myers Squibb; 1996.
  • 64
    • 34247190316 scopus 로고    scopus 로고
    • lisinopril) prescribing information
    • Wilmington, Del; McNeil Consumer & Specialty Pharmaceuticals;
    • Zestril (lisinopril) prescribing information. Wilmington, Del; McNeil Consumer & Specialty Pharmaceuticals; 2002.
    • (2002)
    • Zestril1
  • 65
    • 0030750293 scopus 로고    scopus 로고
    • Valsartan. A review of its pharmacology and therapeutic use in essential hypertension
    • Review
    • Markham A, Goa KL. Valsartan. A review of its pharmacology and therapeutic use in essential hypertension. Drugs. 1997;54:299-311. Review.
    • (1997) Drugs , vol.54 , pp. 299-311
    • Markham, A.1    Goa, K.L.2
  • 66
    • 0030798211 scopus 로고    scopus 로고
    • Clinical safety and tolerability of losartan
    • Weber M. Clinical safety and tolerability of losartan. Clin Ther. 1997;19:604-616.
    • (1997) Clin Ther , vol.19 , pp. 604-616
    • Weber, M.1
  • 67
    • 2342577439 scopus 로고    scopus 로고
    • Irbesartan: A review of its use in hypertension and in the management of diabetic nephropathy
    • Croom KF, Curran MP, Goa KL, Perry CM. Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy. Drugs. 2004;64:999-1028.
    • (2004) Drugs , vol.64 , pp. 999-1028
    • Croom, K.F.1    Curran, M.P.2    Goa, K.L.3    Perry, C.M.4
  • 68
    • 0344303556 scopus 로고    scopus 로고
    • Episodes of depression with attempted suicide after taking valsartan with hydrochlorothiazide [in German]
    • Ullrich H, Passenberg P, Agelink MW. Episodes of depression with attempted suicide after taking valsartan with hydrochlorothiazide [in German]. Dtsch Med Wochenschr. 2003;128:2534-2536.
    • (2003) Dtsch Med Wochenschr , vol.128 , pp. 2534-2536
    • Ullrich, H.1    Passenberg, P.2    Agelink, M.W.3
  • 69
    • 0029775599 scopus 로고    scopus 로고
    • Losartan and reversible psychosis
    • Ahmad S. Losartan and reversible psychosis. Cardiology. 1996;87:569-570.
    • (1996) Cardiology , vol.87 , pp. 569-570
    • Ahmad, S.1
  • 70
    • 0032709918 scopus 로고    scopus 로고
    • Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients
    • Tedesco MA, Ratti G, Mennella S, et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am J Hypertens. 1999;12:1130-1134.
    • (1999) Am J Hypertens , vol.12 , pp. 1130-1134
    • Tedesco, M.A.1    Ratti, G.2    Mennella, S.3
  • 71
    • 0020634830 scopus 로고
    • Update on calcium-channel blocking agents
    • Talbert RL, Bussey HI. Update on calcium-channel blocking agents. Clin Pharm. 1983;2:403-416.
    • (1983) Clin Pharm , vol.2 , pp. 403-416
    • Talbert, R.L.1    Bussey, H.I.2
  • 72
    • 34247251550 scopus 로고    scopus 로고
    • amlodipine ) prescribing information
    • New York, NY: Pfizer Labs;
    • Norvasc (amlodipine ) prescribing information. New York, NY: Pfizer Labs; 2003.
    • (2003)
    • Norvasc1
  • 73
    • 34247234698 scopus 로고    scopus 로고
    • verapamil) prescribing information
    • Chicago, III: GD Searle LLC, a subsidiary of Pharmacia Corporation
    • Calan (verapamil) prescribing information. Chicago, III: GD Searle LLC, a subsidiary of Pharmacia Corporation, 2003.
    • (2003)
    • Calan1
  • 75
    • 0023912516 scopus 로고
    • Organic psychosis caused by diltiazem
    • Busche CJ. Organic psychosis caused by diltiazem. J R Soc Med. 1988;81:296-297.
    • (1988) J R Soc Med , vol.81 , pp. 296-297
    • Busche, C.J.1
  • 76
    • 0027080401 scopus 로고
    • The calcium channel antagonist nifedipine causes confusion when used to treat opiate withdrawal in morphine-dependent patients
    • Silverstone PH, Attenburrow MJ, Robson P. The calcium channel antagonist nifedipine causes confusion when used to treat opiate withdrawal in morphine-dependent patients. Int Clin Psychopharmacol. 1992;7:87-90.
    • (1992) Int Clin Psychopharmacol , vol.7 , pp. 87-90
    • Silverstone, P.H.1    Attenburrow, M.J.2    Robson, P.3
  • 77
    • 0020075236 scopus 로고
    • Effectiveness of verapamil in the treatment of a manic patient
    • Dubovsky SL, Franks RD, Lifschitz M, Coen P. Effectiveness of verapamil in the treatment of a manic patient. Am J Psychiatry. 1982;139:502-504.
    • (1982) Am J Psychiatry , vol.139 , pp. 502-504
    • Dubovsky, S.L.1    Franks, R.D.2    Lifschitz, M.3    Coen, P.4
  • 78
    • 0022189563 scopus 로고
    • Phenelzine-induced hypomania: Effect of verapamil
    • Dubovsky SL, Franks RD, Schrier D, Phenelzine-induced hypomania: effect of verapamil. Biol Psychiatry. 1985;20:1009-1014.
    • (1985) Biol Psychiatry , vol.20 , pp. 1009-1014
    • Dubovsky, S.L.1    Franks, R.D.2    Schrier, D.3
  • 81
    • 0024493361 scopus 로고
    • Verapamil in affective disorders: A controlled, double-blind study
    • Hoschl C, Kozeny J. Verapamil in affective disorders: a controlled, double-blind study. Biol Psychiatry. 1989;25:128-140.
    • (1989) Biol Psychiatry , vol.25 , pp. 128-140
    • Hoschl, C.1    Kozeny, J.2
  • 82
    • 0022453131 scopus 로고
    • Calcium antagonists in mania: A double-blind study of verapamil
    • Dubovsky SL, Franks RD, Allen S, Murphy J. Calcium antagonists in mania: a double-blind study of verapamil. Psychiatry Res. 1986;18:309-320.
    • (1986) Psychiatry Res , vol.18 , pp. 309-320
    • Dubovsky, S.L.1    Franks, R.D.2    Allen, S.3    Murphy, J.4
  • 83
    • 0029801080 scopus 로고    scopus 로고
    • Superiority of lithium over verapamil in mania: A randomized, controlled, single-blind trial
    • Walton SA, Berk M, Brook S. Superiority of lithium over verapamil in mania: a randomized, controlled, single-blind trial. J Clin Psychiatry. 1996;57:543-546.
    • (1996) J Clin Psychiatry , vol.57 , pp. 543-546
    • Walton, S.A.1    Berk, M.2    Brook, S.3
  • 84
    • 0031800861 scopus 로고    scopus 로고
    • Verapamil for the treatment of acute mania: A double-blind, placebo-controlled trial
    • Janicak PG, Sharma RP, Pandey G, Davis JM. Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial. Am J Psychiatry. 1998;155:972-973.
    • (1998) Am J Psychiatry , vol.155 , pp. 972-973
    • Janicak, P.G.1    Sharma, R.P.2    Pandey, G.3    Davis, J.M.4
  • 86
    • 84985823994 scopus 로고
    • Secondary mania associated with diltiazem
    • Palat GK, Movahed A. Secondary mania associated with diltiazem. Clin Cardiol. 1985;8:251.
    • (1985) Clin Cardiol , vol.8 , pp. 251
    • Palat, G.K.1    Movahed, A.2
  • 87
    • 0029947207 scopus 로고    scopus 로고
    • Verapamil maintenance therapy in bipolar patients
    • Giannini AJ, Loiselle RH. Verapamil maintenance therapy in bipolar patients. J Clin Psychiatry. 1996;57:136.
    • (1996) J Clin Psychiatry , vol.57 , pp. 136
    • Giannini, A.J.1    Loiselle, R.H.2
  • 88
    • 0021747089 scopus 로고
    • Verapamil as maintenance treatment in bipolar illness: A case report
    • Gitlin MJ, Weiss J. Verapamil as maintenance treatment in bipolar illness: a case report. J Clin Psychopharmacol. 1984;4:341-343.
    • (1984) J Clin Psychopharmacol , vol.4 , pp. 341-343
    • Gitlin, M.J.1    Weiss, J.2
  • 89
  • 91
    • 0023513449 scopus 로고
    • Verapamil and lithium in maintenance therapy of manic patients
    • Giannini AJ, Verapamil and lithium in maintenance therapy of manic patients. J Clin Pharmacol. 1987;27:980-982.
    • (1987) J Clin Pharmacol , vol.27 , pp. 980-982
    • Giannini, A.J.1
  • 92
    • 0036915721 scopus 로고    scopus 로고
    • Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy
    • Yingling DR, Utter G, Vengalil S, Mason B. Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy. Am J Obstet Gynecol. 2002;187:1711-1712.
    • (2002) Am J Obstet Gynecol , vol.187 , pp. 1711-1712
    • Yingling, D.R.1    Utter, G.2    Vengalil, S.3    Mason, B.4
  • 93
    • 0031690746 scopus 로고    scopus 로고
    • Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness
    • Pazzaglia PJ, Post RM, Ketter TA, et al. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.J Clin Psychopharmacol. 1998;18:404-413.
    • (1998) J Clin Psychopharmacol , vol.18 , pp. 404-413
    • Pazzaglia, P.J.1    Post, R.M.2    Ketter, T.A.3
  • 95
    • 0035079933 scopus 로고    scopus 로고
    • Nicardipine improves the antidepressant action of ECT but does not improve cognition
    • Dubovsky SL, Buzan R, Thomas M, Kassner C, Cullum CM. Nicardipine improves the antidepressant action of ECT but does not improve cognition. J ECT. 2001;17:3-10.
    • (2001) J ECT , vol.17 , pp. 3-10
    • Dubovsky, S.L.1    Buzan, R.2    Thomas, M.3    Kassner, C.4    Cullum, C.M.5
  • 96
    • 0035072237 scopus 로고    scopus 로고
    • A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'
    • Taragano FE, Allegri R, Vicario A, Bagnatti P, Lyketsos CG. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'. Int J Geriatr Psychiatry. 2001;16:254-260.
    • (2001) Int J Geriatr Psychiatry , vol.16 , pp. 254-260
    • Taragano, F.E.1    Allegri, R.2    Vicario, A.3    Bagnatti, P.4    Lyketsos, C.G.5
  • 97
    • 25844505517 scopus 로고    scopus 로고
    • A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression
    • Taragano FE, Bagnatti P, Allegri RF. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression". Int Psychogeriatr. 2005;17:487-498.
    • (2005) Int Psychogeriatr , vol.17 , pp. 487-498
    • Taragano, F.E.1    Bagnatti, P.2    Allegri, R.F.3
  • 98
    • 0023908659 scopus 로고
    • Controlled study of verapamil for treatment of panic disorder
    • Klein E, Uhde TW. Controlled study of verapamil for treatment of panic disorder. Am J Psychiatry 1988;145:431-434.
    • (1988) Am J Psychiatry , vol.145 , pp. 431-434
    • Klein, E.1    Uhde, T.W.2
  • 99
    • 0030455126 scopus 로고    scopus 로고
    • Calcium channel blockers for anxiety disorders?
    • Balon R, Ramesh C. Calcium channel blockers for anxiety disorders? Ann Clin Psychiatry. 1996;8:215-220.
    • (1996) Ann Clin Psychiatry , vol.8 , pp. 215-220
    • Balon, R.1    Ramesh, C.2
  • 100
    • 0014556238 scopus 로고
    • Distribution and urinary excretion of furosemide in the rat
    • Seno S, Shaw SM, Christian JE. Distribution and urinary excretion of furosemide in the rat. J Pharm Sci. 1969;58:935-938.
    • (1969) J Pharm Sci , vol.58 , pp. 935-938
    • Seno, S.1    Shaw, S.M.2    Christian, J.E.3
  • 101
    • 0019311197 scopus 로고
    • Thiazide-induced hypercalcemia in a manic-depressive patient
    • Gammon GD, Docherty JP. Thiazide-induced hypercalcemia in a manic-depressive patient. Am J Psychiatry. 1980;137:1453-1455.
    • (1980) Am J Psychiatry , vol.137 , pp. 1453-1455
    • Gammon, G.D.1    Docherty, J.P.2
  • 102
    • 4844228396 scopus 로고    scopus 로고
    • Clinical studies of thiazide-induced hyponatremia
    • Chow KM, Kwan BC, Szeto CC. Clinical studies of thiazide-induced hyponatremia. J Natl Med Assoc. 2004;96:1305-1308.
    • (2004) J Natl Med Assoc , vol.96 , pp. 1305-1308
    • Chow, K.M.1    Kwan, B.C.2    Szeto, C.C.3
  • 103
    • 0029964623 scopus 로고    scopus 로고
    • Reversible exogenous psychosis in thiazide-induced hyponatremia of 97 mmol/l [in German]
    • Haensch CA, Hennen G, Jorg J. Reversible exogenous psychosis in thiazide-induced hyponatremia of 97 mmol/l [in German]. Nervenarzt. 1996;67:319-322.
    • (1996) Nervenarzt , vol.67 , pp. 319-322
    • Haensch, C.A.1    Hennen, G.2    Jorg, J.3
  • 104
    • 1242339750 scopus 로고    scopus 로고
    • Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors
    • Rosner MH. Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors. Am J Med Sci. 2004;327:109-111.
    • (2004) Am J Med Sci , vol.327 , pp. 109-111
    • Rosner, M.H.1
  • 105
    • 0036119819 scopus 로고    scopus 로고
    • Hyponatremia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: A retrospective controlled study in an inpatient unit
    • Kirby D, Ames D. Hyponatremia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry. 2002;17:231-237.
    • (2002) Int J Geriatr Psychiatry , vol.17 , pp. 231-237
    • Kirby, D.1    Ames, D.2
  • 106
    • 0022239237 scopus 로고
    • Depression after treatment with thiazide diuretics for hypertension
    • Okada F, Kirby D, Harrigan S, Ames D. Depression after treatment with thiazide diuretics for hypertension. Am J Psychiatry. 1985;142:1101-1102.
    • (1985) Am J Psychiatry , vol.142 , pp. 1101-1102
    • Okada, F.1    Kirby, D.2    Harrigan, S.3    Ames, D.4
  • 107
    • 0021866729 scopus 로고
    • Diuretic-induced lithium toxicity presenting as mania
    • Nurnberger JI Jr. Diuretic-induced lithium toxicity presenting as mania. J Nerv Ment Dis. 1985;173:316-318.
    • (1985) J Nerv Ment Dis , vol.173 , pp. 316-318
    • Nurnberger Jr., J.I.1
  • 108
    • 0032766653 scopus 로고    scopus 로고
    • Drug-induced cognition disorders in the elderly: Incidence, prevention and management
    • Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf. 1999;21:101-122.
    • (1999) Drug Saf , vol.21 , pp. 101-122
    • Gray, S.L.1    Lai, K.V.2    Larson, E.B.3
  • 109
  • 110
    • 0344417101 scopus 로고    scopus 로고
    • Wernicke's encephalopathy induced by magnesium depletion
    • McLean J, Manchip S. Wernicke's encephalopathy induced by magnesium depletion. Lancet. 1999;353:1768.
    • (1999) Lancet , vol.353 , pp. 1768
    • McLean, J.1    Manchip, S.2
  • 111
    • 34247279922 scopus 로고    scopus 로고
    • Acetazolamide prescribing information. Hawthorne, NY: Taro Pharmaceuticals; 1997.
    • Acetazolamide prescribing information. Hawthorne, NY: Taro Pharmaceuticals; 1997.
  • 112
    • 0017744637 scopus 로고
    • Carbonic anhydrase inhibitor side effects. Serum chemical analysis
    • Epstein DL, Grant WM. Carbonic anhydrase inhibitor side effects. Serum chemical analysis. Arch Opthalmol. 1977;95:1378-1382.
    • (1977) Arch Opthalmol , vol.95 , pp. 1378-1382
    • Epstein, D.L.1    Grant, W.M.2
  • 113
    • 0017339834 scopus 로고
    • Acetazolamide delirium
    • Rowe TO. Acetazolamide delirium. Am J Psychiatry. 1977;134:587-588.
    • (1977) Am J Psychiatry , vol.134 , pp. 587-588
    • Rowe, T.O.1
  • 114
    • 0029026116 scopus 로고
    • Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysis
    • Schwenk MH, St Peter WL, Meese MG, Singhal PC. Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysis. Pharmacotherapy. 1995;15:522-527.
    • (1995) Pharmacotherapy , vol.15 , pp. 522-527
    • Schwenk, M.H.1    St Peter, W.L.2    Meese, M.G.3    Singhal, P.C.4
  • 115
    • 3042673923 scopus 로고    scopus 로고
    • Acute confusional syndrome associated with obstructive sleep apnea aggravated by acidosis secondary to oral acetazolamide treatment [in Spanish]
    • Miguel E, Guell R, Anton A, Montiel JA, Mayos M. Acute confusional syndrome associated with obstructive sleep apnea aggravated by acidosis secondary to oral acetazolamide treatment [in Spanish]. Arch Bronconeumol. 2004;40:283-286.
    • (2004) Arch Bronconeumol , vol.40 , pp. 283-286
    • Miguel, E.1    Guell, R.2    Anton, A.3    Montiel, J.A.4    Mayos, M.5
  • 117
    • 31944441209 scopus 로고    scopus 로고
    • Acetazolamide improves central sleep apnea in heart failure: A double-blind, prospective study
    • Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med. 2006;173:234-237.
    • (2006) Am J Respir Crit Care Med , vol.173 , pp. 234-237
    • Javaheri, S.1
  • 118
    • 0031756675 scopus 로고    scopus 로고
    • Acetazolamide in the treatment of acute mania. A case report
    • Brandt C, Grunze H, Normann C, Walden J. Acetazolamide in the treatment of acute mania. A case report. Neuropsychobiology. 1998;38:202-203.
    • (1998) Neuropsychobiology , vol.38 , pp. 202-203
    • Brandt, C.1    Grunze, H.2    Normann, C.3    Walden, J.4
  • 119
    • 0028077161 scopus 로고
    • Acetazolamide in bipolar affective disorders
    • Hayes SG. Acetazolamide in bipolar affective disorders. Ann Clin Psychiatry. 1994;6:91-98.
    • (1994) Ann Clin Psychiatry , vol.6 , pp. 91-98
    • Hayes, S.G.1
  • 120
    • 0021670332 scopus 로고
    • Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis
    • Inoue H, Hazama H, Hamazoe K, et al. Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis. Folia Psychiatr Neurol Jpn. 1984;38:425-436.
    • (1984) Folia Psychiatr Neurol Jpn , vol.38 , pp. 425-436
    • Inoue, H.1    Hazama, H.2    Hamazoe, K.3
  • 121
    • 34247199107 scopus 로고    scopus 로고
    • Catapres-TTS (clonidine) prescribing information. Indianapolis, Ind: Boeringer-Mannheim; 2006.
    • Catapres-TTS (clonidine) prescribing information. Indianapolis, Ind: Boeringer-Mannheim; 2006.
  • 122
    • 0037344546 scopus 로고    scopus 로고
    • Neuropsychiatric effects of cardiovascular drug therapy
    • Keller S, Frishman WH. Neuropsychiatric effects of cardiovascular drug therapy. Cardiol Rev. 2003;11:73-93.
    • (2003) Cardiol Rev , vol.11 , pp. 73-93
    • Keller, S.1    Frishman, W.H.2
  • 123
    • 0020416916 scopus 로고
    • Psychiatric side effects of antihypertensive drugs other than reserpine
    • Paykel ES, Fleminger R, Watson JP. Psychiatric side effects of antihypertensive drugs other than reserpine. J Clin Psychopharmacol. 1982;2:14-39.
    • (1982) J Clin Psychopharmacol , vol.2 , pp. 14-39
    • Paykel, E.S.1    Fleminger, R.2    Watson, J.P.3
  • 124
    • 0017683357 scopus 로고
    • Acute hallucinosis due to clonidine
    • Enoch MD, Hammad GE. Acute hallucinosis due to clonidine. Curr Med Res Opin. 1977;4:670-671.
    • (1977) Curr Med Res Opin , vol.4 , pp. 670-671
    • Enoch, M.D.1    Hammad, G.E.2
  • 125
    • 0025787378 scopus 로고
    • Clonidine and scopolamine: Differences and similarities in how they change human information processing
    • Callaway E, Halliday R, Naylor H, Brandeis D. Clonidine and scopolamine: differences and similarities in how they change human information processing. Prog Neuropsychopharmacol Biol Psychiatry. 1991;15:497-502.
    • (1991) Prog Neuropsychopharmacol Biol Psychiatry , vol.15 , pp. 497-502
    • Callaway, E.1    Halliday, R.2    Naylor, H.3    Brandeis, D.4
  • 127
    • 0032695861 scopus 로고    scopus 로고
    • A meta-analysis of clonidine for symptoms of attention deficit hyperactivity disorder
    • Conner D, Fletcher K, Swanson J. A meta-analysis of clonidine for symptoms of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999;58:1551-1559.
    • (1999) J Am Acad Child Adolesc Psychiatry , vol.58 , pp. 1551-1559
    • Conner, D.1    Fletcher, K.2    Swanson, J.3
  • 128
    • 0037176827 scopus 로고    scopus 로고
    • Treatment of ADHD in children with tics: A randomized controlled trial
    • Kurlan R. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002;58:527-536.
    • (2002) Neurology , vol.58 , pp. 527-536
    • Kurlan, R.1
  • 129
    • 27744598976 scopus 로고    scopus 로고
    • Attention-deficit/ hyperactivity disorder among adolescents: A review of the diagnosis, treatment, and clinical implications
    • Wolraich ML, Wibbelsman CI, Brown TE, et al. Attention-deficit/ hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005;115:1734-1746.
    • (2005) Pediatrics , vol.115 , pp. 1734-1746
    • Wolraich, M.L.1    Wibbelsman, C.I.2    Brown, T.E.3
  • 130
    • 84921705631 scopus 로고    scopus 로고
    • Alpha2 adrenergic agonists for the management of opioid withdrawal
    • CD002024
    • Gowing L, Farrell M, Ali R, White J. Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev. 2003;2:CD002024.
    • (2003) Cochrane Database Syst Rev , pp. 2
    • Gowing, L.1    Farrell, M.2    Ali, R.3    White, J.4
  • 131
    • 23944485969 scopus 로고    scopus 로고
    • Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: A randomized trial
    • Collins ED, Kleber HD, Whittington RA, Heitler NE. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. JAMA. 2005;294:903-913.
    • (2005) JAMA , vol.294 , pp. 903-913
    • Collins, E.D.1    Kleber, H.D.2    Whittington, R.A.3    Heitler, N.E.4
  • 133
    • 0023202244 scopus 로고
    • Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome
    • Baumgartner GR, Rowen RC. Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med. 1987;147:1223-1226.
    • (1987) Arch Intern Med , vol.147 , pp. 1223-1226
    • Baumgartner, G.R.1    Rowen, R.C.2
  • 134
    • 0023479375 scopus 로고
    • Clonidine and alcohol withdrawal
    • Review
    • Cushman P Jr. Clonidine and alcohol withdrawal. Adv Alcohol Subst Abuse. 1987;7:17-28. Review.
    • (1987) Adv Alcohol Subst Abuse , vol.7 , pp. 17-28
    • Cushman Jr., P.1
  • 136
    • 0028269249 scopus 로고
    • Treatment of alcohol withdrawal syndrome
    • Review
    • Ozdemir V, Bremner KE, Naranjo CA. Treatment of alcohol withdrawal syndrome. Ann Med. 1994;26:101-105. Review.
    • (1994) Ann Med , vol.26 , pp. 101-105
    • Ozdemir, V.1    Bremner, K.E.2    Naranjo, C.A.3
  • 137
    • 0035692207 scopus 로고    scopus 로고
    • Pharmacological options for the treatment of Tourette's disorder
    • Review
    • Jimenez-Jimenez FJ, Garcia-Ruiz PJ. Pharmacological options for the treatment of Tourette's disorder. Drugs. 2001;61:2207-2220. Review.
    • (2001) Drugs , vol.61 , pp. 2207-2220
    • Jimenez-Jimenez, F.J.1    Garcia-Ruiz, P.J.2
  • 138
    • 0033667056 scopus 로고    scopus 로고
    • Gilles de la Tourette syndrome: Symptomatic treatment based on evidence
    • Review
    • Robertson MM, Stern JS. Gilles de la Tourette syndrome: symptomatic treatment based on evidence. Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:160-715. Review.
    • (2000) Eur Child Adolesc Psychiatry , vol.9 , Issue.SUPPL. 1 , pp. 160-715
    • Robertson, M.M.1    Stern, J.S.2
  • 142
    • 0018856249 scopus 로고
    • Memory enhancement in Korsakoff's psychosis by clonidine: Further evidence for a noradrenergic deficit
    • McEntee WJ, Mair RG. Memory enhancement in Korsakoff's psychosis by clonidine: further evidence for a noradrenergic deficit. Ann Neurol. 1980;7:466-470.
    • (1980) Ann Neurol , vol.7 , pp. 466-470
    • McEntee, W.J.1    Mair, R.G.2
  • 143
    • 0026183418 scopus 로고
    • The effect of clonidine in the treatment of acute mania
    • Tudorache B, Diacicov S. The effect of clonidine in the treatment of acute mania. Rom J Neurol Psychiatry. 1991;29:209-213.
    • (1991) Rom J Neurol Psychiatry , vol.29 , pp. 209-213
    • Tudorache, B.1    Diacicov, S.2
  • 144
    • 0031005348 scopus 로고    scopus 로고
    • Psychopharmacologic treatment of pathologic aggression
    • Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am. 1997;20:427-51.
    • (1997) Psychiatr Clin North Am , vol.20 , pp. 427-451
    • Fava, M.1
  • 145
    • 0023472869 scopus 로고
    • Effects of antihypertensive medications on vitality and well-being
    • Levine S, Croog SH, Sudilovsky A, Testa MA. Effects of antihypertensive medications on vitality and well-being. J Fam Pract. 1987;25:357-363.
    • (1987) J Fam Pract , vol.25 , pp. 357-363
    • Levine, S.1    Croog, S.H.2    Sudilovsky, A.3    Testa, M.A.4
  • 146
    • 0025366197 scopus 로고
    • Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of Life Research Group
    • Schoenberger JA, Croog SH, Sudilovsky A, Levine S, Baume RM. Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of Life Research Group. Am J Hypertens. 1990;3:123-132.
    • (1990) Am J Hypertens , vol.3 , pp. 123-132
    • Schoenberger, J.A.1    Croog, S.H.2    Sudilovsky, A.3    Levine, S.4    Baume, R.M.5
  • 147
    • 0016166418 scopus 로고
    • Methyldopa-induced decrease in mental activity
    • Adler S. Methyldopa-induced decrease in mental activity. JAMA. 1974;230:1428-1429.
    • (1974) JAMA , vol.230 , pp. 1428-1429
    • Adler, S.1
  • 149
    • 0036668209 scopus 로고    scopus 로고
    • Effects of six anti-hypertensive medications on cognitive performance
    • Muldoon MF, Waldstein SR, Ryan CM, et al. Effects of six anti-hypertensive medications on cognitive performance. J Hypertens. 2002;20:1643-1652.
    • (2002) J Hypertens , vol.20 , pp. 1643-1652
    • Muldoon, M.F.1    Waldstein, S.R.2    Ryan, C.M.3
  • 150
    • 0018179190 scopus 로고
    • Antihypertensive drugs and depression: A reappraisal
    • Bant WP. Antihypertensive drugs and depression: a reappraisal. Psychol Med. 1978;8:275-283.
    • (1978) Psychol Med , vol.8 , pp. 275-283
    • Bant, W.P.1
  • 151
    • 0019489448 scopus 로고
    • Psychiatric complications of antihypertensive medications
    • Pottash AL, Black HR, Gold MS. Psychiatric complications of antihypertensive medications. J Nerv Ment Dis. 1981;169:430-438.
    • (1981) J Nerv Ment Dis , vol.169 , pp. 430-438
    • Pottash, A.L.1    Black, H.R.2    Gold, M.S.3
  • 152
    • 0014109483 scopus 로고
    • Depression with the use of alpha-methyldopa
    • McKinney WT Jr, Kane FJ Jr. Depression with the use of alpha-methyldopa. Am J Psychiatry. 1967;124:80-81.
    • (1967) Am J Psychiatry , vol.124 , pp. 80-81
    • McKinney Jr, W.T.1    Kane Jr., F.J.2
  • 153
    • 0027730558 scopus 로고
    • Critical review of data supporting affective disorder caused by nonpsychotropic medication
    • Long TD, Kathol RG. Critical review of data supporting affective disorder caused by nonpsychotropic medication. Ann Clin Psychiatry. 1993;5:259-270.
    • (1993) Ann Clin Psychiatry , vol.5 , pp. 259-270
    • Long, T.D.1    Kathol, R.G.2
  • 154
    • 0020567453 scopus 로고
    • Alpha-methyldopa and depression: A clinical study and review of the literature
    • DeMuth GW, Ackerman SH. Alpha-methyldopa and depression: a clinical study and review of the literature. Am J Psychiatry. 1983;140:534-538.
    • (1983) Am J Psychiatry , vol.140 , pp. 534-538
    • DeMuth, G.W.1    Ackerman, S.H.2
  • 155
    • 0015789188 scopus 로고
    • A therapeutic paradox? Combined treatment of Parkinson's disease with levodopa and methyldopa
    • Kofman OS. A therapeutic paradox? Combined treatment of Parkinson's disease with levodopa and methyldopa. Arch Neurol. 1973;29:120-121.
    • (1973) Arch Neurol , vol.29 , pp. 120-121
    • Kofman, O.S.1
  • 156
    • 0015259415 scopus 로고
    • Methyldopa as an adjunct to levodopa treatment of Parkinson's disease
    • Sweet RD, Lee JE, McDowell FH. Methyldopa as an adjunct to levodopa treatment of Parkinson's disease. Clin Pharmacol Ther. 1972;13:23-27.
    • (1972) Clin Pharmacol Ther , vol.13 , pp. 23-27
    • Sweet, R.D.1    Lee, J.E.2    McDowell, F.H.3
  • 157
    • 0015169546 scopus 로고
    • Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease
    • Sweet RD, Lee JE, McDowell F. Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease. Trans Am Neurol Assoc. 1971;96:59-65.
    • (1971) Trans Am Neurol Assoc , vol.96 , pp. 59-65
    • Sweet, R.D.1    Lee, J.E.2    McDowell, F.3
  • 158
    • 0018128466 scopus 로고
    • Paranoid-hallucinatory state induced in a depressive patient by methyldopa: A case report
    • Endo M, Hirai K, Ohara M. Paranoid-hallucinatory state induced in a depressive patient by methyldopa: a case report. Psychoneuroendocrinology. 1978;3:211-215.
    • (1978) Psychoneuroendocrinology , vol.3 , pp. 211-215
    • Endo, M.1    Hirai, K.2    Ohara, M.3
  • 159
    • 0017169314 scopus 로고
    • Acute organic brain syndrome psychosis with methyldopa therapy: Case report
    • Hawkins DJ. Acute organic brain syndrome psychosis with methyldopa therapy: case report. Mo Med. 1976;73:476, 481.
    • (1976) Mo Med , vol.73 , Issue.476 , pp. 481
    • Hawkins, D.J.1
  • 160
    • 0001705757 scopus 로고
    • Depressive reactions in hypertensive patients; a comparison of those treated with Rauwolfia and those receiving no specific antihypertensive treatment
    • Quetsch RM, Achor RW, Litin EM, Faucett RL. Depressive reactions in hypertensive patients; a comparison of those treated with Rauwolfia and those receiving no specific antihypertensive treatment. Circulation. 1959;19:366-375.
    • (1959) Circulation , vol.19 , pp. 366-375
    • Quetsch, R.M.1    Achor, R.W.2    Litin, E.M.3    Faucett, R.L.4
  • 161
    • 0012604122 scopus 로고
    • Treatment of hypertensive patients with Rauwolfia compounds and reserpine; depressive and psychotic changes
    • Kass I, Brown EC. Treatment of hypertensive patients with Rauwolfia compounds and reserpine; depressive and psychotic changes. JAMA. 1955;159:1513-1516.
    • (1955) JAMA , vol.159 , pp. 1513-1516
    • Kass, I.1    Brown, E.C.2
  • 162
    • 0012604123 scopus 로고
    • Drug-induced depression; fact or fallacy
    • Ayd FJ Jr. Drug-induced depression; fact or fallacy. N Y State J Med. 1958;58:354-356.
    • (1958) N Y State J Med , vol.58 , pp. 354-356
    • Ayd Jr., F.J.1
  • 163
    • 84959070165 scopus 로고
    • Mental depression in hypertensive patients treated for long periods with large doses of reserpine
    • Fries ED. Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med. 1954;251:1006-1008.
    • (1954) N Engl J Med , vol.251 , pp. 1006-1008
    • Fries, E.D.1
  • 164
    • 0026014277 scopus 로고
    • Neuropsychiatric considerations in the treatment of hypertension
    • Rauch SL, Stern TA, Zusman RM. Neuropsychiatric considerations in the treatment of hypertension. Int J Psychiatry Med. 1991;21:291-308.
    • (1991) Int J Psychiatry Med , vol.21 , pp. 291-308
    • Rauch, S.L.1    Stern, T.A.2    Zusman, R.M.3
  • 165
    • 0028006802 scopus 로고
    • Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program
    • Applegate WB, Pressel S, Wittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med. 1994;154:2154-2160.
    • (1994) Arch Intern Med , vol.154 , pp. 2154-2160
    • Applegate, W.B.1    Pressel, S.2    Wittes, J.3
  • 166
    • 0025219286 scopus 로고
    • Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study
    • Goldstein G, Materson BJ, Cushman WC, et al. Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. Hypertension. 1990;15:361-369.
    • (1990) Hypertension , vol.15 , pp. 361-369
    • Goldstein, G.1    Materson, B.J.2    Cushman, W.C.3
  • 167
    • 0029787839 scopus 로고    scopus 로고
    • Aspects of tolerability of centrally acting antihypertensive drugs
    • Webster J, Koch HF. Aspects of tolerability of centrally acting antihypertensive drugs. J Cardiovasc Pharmacol. 1996;27(suppl 3):S49-S54.
    • (1996) J Cardiovasc Pharmacol , vol.27 , Issue.SUPPL. 3
    • Webster, J.1    Koch, H.F.2
  • 168
    • 0022292736 scopus 로고
    • Biobehavioral sequellae associated with adrenergic-inhibiting antihypertensive agents: A critical review
    • Rosen RC, Kostis JB. Biobehavioral sequellae associated with adrenergic-inhibiting antihypertensive agents: a critical review. Health Psychol. 1985;4:579-604.
    • (1985) Health Psychol , vol.4 , pp. 579-604
    • Rosen, R.C.1    Kostis, J.B.2
  • 169
    • 0043132076 scopus 로고    scopus 로고
    • The myth of reserpine-induced depression: Role in the historical development of the monoamine hypothesis
    • Aumeister AA, Hawkins MF, Uzelac SM. The myth of reserpine-induced depression: role in the historical development of the monoamine hypothesis. J Hist Neurosci. 2003;12:207-220.
    • (2003) J Hist Neurosci , vol.12 , pp. 207-220
    • Aumeister, A.A.1    Hawkins, M.F.2    Uzelac, S.M.3
  • 170
    • 0032766653 scopus 로고    scopus 로고
    • Drug-induced cognition disorders in the elderly: Incidence, prevention and management
    • Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf. 1999;21:101-122.
    • (1999) Drug Saf , vol.21 , pp. 101-122
    • Gray, S.L.1    Lai, K.V.2    Larson, E.B.3
  • 172
    • 0019948154 scopus 로고
    • Reserpine withdrawal psychosis: The possible role of denervation supersensitivity of receptors
    • Kent TA, Wilber RD. Reserpine withdrawal psychosis: the possible role of denervation supersensitivity of receptors. J Nerv Ment Dis. 1982;170:502-504.
    • (1982) J Nerv Ment Dis , vol.170 , pp. 502-504
    • Kent, T.A.1    Wilber, R.D.2
  • 175
    • 0018421733 scopus 로고
    • Lithium plus reserpine in refractory manic patients
    • Bacher NM, Lewis HA. Lithium plus reserpine in refractory manic patients. Am J Psychiatry. 1979;136:811-814.
    • (1979) Am J Psychiatry , vol.136 , pp. 811-814
    • Bacher, N.M.1    Lewis, H.A.2
  • 176
    • 34247190828 scopus 로고
    • The effect of reserpine on the duration of manic attacks
    • Watt DC. The effect of reserpine on the duration of manic attacks. J Neurol Neurosurg Psychiatry. 1958;21:297-300.
    • (1958) J Neurol Neurosurg Psychiatry , vol.21 , pp. 297-300
    • Watt, D.C.1
  • 177
    • 0030845973 scopus 로고    scopus 로고
    • Clozapine-reserpine combination for refractory psychosis
    • Healy DJ, Dalack GW, Meador-Woodruff JH. Clozapine-reserpine combination for refractory psychosis. Schizophr Res. 1997;25:259-260.
    • (1997) Schizophr Res , vol.25 , pp. 259-260
    • Healy, D.J.1    Dalack, G.W.2    Meador-Woodruff, J.H.3
  • 178
    • 0030463907 scopus 로고    scopus 로고
    • Risperidone-reserpine combination in refractory psychosis
    • Solon EN. Risperidone-reserpine combination in refractory psychosis. Schizophr Res. 1996;22:265-266.
    • (1996) Schizophr Res , vol.22 , pp. 265-266
    • Solon, E.N.1
  • 179
    • 0022384284 scopus 로고
    • Reserpine and phencyclidine-associated psychosis: Three case reports
    • Berlant JL. Reserpine and phencyclidine-associated psychosis: three case reports. J Clin Psychiatry. 1985;46:542-544.
    • (1985) J Clin Psychiatry , vol.46 , pp. 542-544
    • Berlant, J.L.1
  • 180
    • 0022538473 scopus 로고
    • Neuroleptics and reserpine in refractory psychoses
    • Berlant JL. Neuroleptics and reserpine in refractory psychoses. J Clin Psychopharmacol. 1986;6:180-184.
    • (1986) J Clin Psychopharmacol , vol.6 , pp. 180-184
    • Berlant, J.L.1
  • 181
    • 0023195609 scopus 로고
    • Reserpine augmentation of desipramine in refractory depression: Clinical and neurobiological effects
    • Price LH, Charney DS, Heninger GR. Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects. Psychopharmacology (Berl). 1987;92:431-437.
    • (1987) Psychopharmacology (Berl) , vol.92 , pp. 431-437
    • Price, L.H.1    Charney, D.S.2    Heninger, G.R.3
  • 182
    • 0028173804 scopus 로고
    • Adverse effects of alpha 1-adrenergic blocking drugs
    • Carruthers SG. Adverse effects of alpha 1-adrenergic blocking drugs. Drug Saf. 1994;11:12-20.
    • (1994) Drug Saf , vol.11 , pp. 12-20
    • Carruthers, S.G.1
  • 183
    • 11144248215 scopus 로고    scopus 로고
    • Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: A systematic review of efficacy and adverse effects
    • MacDonald R, Wilt TJ, Howe RW. Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects. BJU Int. 2004;94:1263-1270.
    • (2004) BJU Int , vol.94 , pp. 1263-1270
    • MacDonald, R.1    Wilt, T.J.2    Howe, R.W.3
  • 184
    • 2342423800 scopus 로고    scopus 로고
    • Extended-release alfuzosin hydrochloride: A new alpha-adrenergic receptor antagonist for symptomatic benign prostatic hyperplasia
    • Guay DR. Extended-release alfuzosin hydrochloride: a new alpha-adrenergic receptor antagonist for symptomatic benign prostatic hyperplasia. Am J Geriatr Pharmacother. 2004;2:14-23.
    • (2004) Am J Geriatr Pharmacother , vol.2 , pp. 14-23
    • Guay, D.R.1
  • 185
    • 0025633678 scopus 로고
    • Antihypertensive medications and depression
    • Beers MH, Passman LJ. Antihypertensive medications and depression. Drugs. 1990;40:792-799.
    • (1990) Drugs , vol.40 , pp. 792-799
    • Beers, M.H.1    Passman, L.J.2
  • 186
    • 33644920665 scopus 로고    scopus 로고
    • Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism
    • Pessina AC, Ciccariello L, Perrone F, et al. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Nutr Metab Cardiovasc Dis. 2006;16:137-147.
    • (2006) Nutr Metab Cardiovasc Dis , vol.16 , pp. 137-147
    • Pessina, A.C.1    Ciccariello, L.2    Perrone, F.3
  • 187
    • 0020761291 scopus 로고
    • Neuropsychiatric manifestations of antihypertensive medications
    • Benson D, Peterson LG, Bartay J. Neuropsychiatric manifestations of antihypertensive medications. Psychiatr Med. 1983;1:205-214.
    • (1983) Psychiatr Med , vol.1 , pp. 205-214
    • Benson, D.1    Peterson, L.G.2    Bartay, J.3
  • 188
    • 85007686092 scopus 로고    scopus 로고
    • Drug induced psychosis with doxazosin
    • Evans M, Perera PW, Donoghue J. Drug induced psychosis with doxazosin. BMJ. 1997;314:1869.
    • (1997) BMJ , vol.314 , pp. 1869
    • Evans, M.1    Perera, P.W.2    Donoghue, J.3
  • 189
    • 0022970473 scopus 로고
    • Neuropsychiatric complications related to use of prazosin in patients with renal failure
    • Chin DKF Cho Ak, Tse CY. Neuropsychiatric complications related to use of prazosin in patients with renal failure. BMJ. 1986; 293:1347.
    • (1986) BMJ , vol.293 , pp. 1347
    • Chin, D.K.F.1    Cho, A.2    Tse, C.Y.3
  • 190
    • 0024591107 scopus 로고
    • Effects of antihypertensive therapy on blood pressure control, cognition, and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide
    • Lasser NL, Nash J, Lasser VI, Hamill SJ, Batey DM. Effects of antihypertensive therapy on blood pressure control, cognition, and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide. Am J Med. 1989;86:98-103.
    • (1989) Am J Med , vol.86 , pp. 98-103
    • Lasser, N.L.1    Nash, J.2    Lasser, V.I.3    Hamill, S.J.4    Batey, D.M.5
  • 191
    • 0037315260 scopus 로고    scopus 로고
    • Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: A placebo-controlled study
    • Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003;160:371-373.
    • (2003) Am J Psychiatry , vol.160 , pp. 371-373
    • Raskind, M.A.1    Peskind, E.R.2    Kanter, E.D.3
  • 192
    • 0036007450 scopus 로고    scopus 로고
    • The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder
    • Taylor F, Raskind MA. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22:82-85.
    • (2002) J Clin Psychopharmacol , vol.22 , pp. 82-85
    • Taylor, F.1    Raskind, M.A.2
  • 193
    • 0242596600 scopus 로고    scopus 로고
    • Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder
    • Peskind ER, Bonner LT, Hoff DJ, Raskind MA. Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder. J Geriatr Psychiatry Neurol. 2003;16:165-671.
    • (2003) J Geriatr Psychiatry Neurol , vol.16 , pp. 165-671
    • Peskind, E.R.1    Bonner, L.T.2    Hoff, D.J.3    Raskind, M.A.4
  • 194
    • 0036076451 scopus 로고    scopus 로고
    • Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder
    • Raskind MA, Thompson C, Petrie EC, et al. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. J Clin Psychiatry. 2002;63:565-568.
    • (2002) J Clin Psychiatry , vol.63 , pp. 565-568
    • Raskind, M.A.1    Thompson, C.2    Petrie, E.C.3
  • 195
    • 33745610463 scopus 로고    scopus 로고
    • Sleep disturbances in patients with post-traumatic stress disorder: Epidemiology, impact and approaches to management
    • Maher MJ, Rego SA, Asnis GM. Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management. CNS Drugs. 2006;20:567-590.
    • (2006) CNS Drugs , vol.20 , pp. 567-590
    • Maher, M.J.1    Rego, S.A.2    Asnis, G.M.3
  • 196
    • 33644820533 scopus 로고    scopus 로고
    • Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder
    • Taylor FB, Lowe K, Thompson C, et al. Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder. Biol Psychiatry. 2006;59:577-581.
    • (2006) Biol Psychiatry , vol.59 , pp. 577-581
    • Taylor, F.B.1    Lowe, K.2    Thompson, C.3
  • 197
    • 34247275399 scopus 로고    scopus 로고
    • The dual risks of depression and hypertension: Treatment of coexisting disorders requires vigilance
    • online, Available at:, Accessed December
    • Shrivastava S, Kochar MS. The dual risks of depression and hypertension: treatment of coexisting disorders requires vigilance. Postgrad Med [online]. Available at: http://www.postgradmed.com/issues/2002/06_02/ shrivastava.htm. Accessed December 2006.
    • (2006) Postgrad Med
    • Shrivastava, S.1    Kochar, M.S.2
  • 198
    • 0020510918 scopus 로고
    • Propranolol-hydralazine combination in essential hypertension
    • Stevens JD, Binstok G, Mullane JF, et al. Propranolol-hydralazine combination in essential hypertension. Clin Ther. 1983;5:525-539.
    • (1983) Clin Ther , vol.5 , pp. 525-539
    • Stevens, J.D.1    Binstok, G.2    Mullane, J.F.3
  • 199
    • 34247215243 scopus 로고
    • Acute psychosis as a complication of hydralazine therapy in essential hypertension
    • Moser M, Syner J, Malitz S, Mattingly TW. Acute psychosis as a complication of hydralazine therapy in essential hypertension. JAMA. 1953;152:1329-1331.
    • (1953) JAMA , vol.152 , pp. 1329-1331
    • Moser, M.1    Syner, J.2    Malitz, S.3    Mattingly, T.W.4
  • 200
    • 0018746416 scopus 로고
    • Precipitation of heart failure following sudden withdrawal of hydralazine
    • Black JR, Mehta J. Precipitation of heart failure following sudden withdrawal of hydralazine. Chest. 1979;75:724-725.
    • (1979) Chest , vol.75 , pp. 724-725
    • Black, J.R.1    Mehta, J.2
  • 201
    • 0025219286 scopus 로고
    • Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study
    • Goldstein G, Materson BJ, Cushman WC, et al. Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. Hypertension. 1990;15:361-369.
    • (1990) Hypertension , vol.15 , pp. 361-369
    • Goldstein, G.1    Materson, B.J.2    Cushman, W.C.3
  • 203
    • 0014036588 scopus 로고
    • Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus
    • Alarcon-Segovia D, Wakim KG, Worthington JW, Ward LE. Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus. Medicine (Baltimore). 1967;46:1-33.
    • (1967) Medicine (Baltimore) , vol.46 , pp. 1-33
    • Alarcon-Segovia, D.1    Wakim, K.G.2    Worthington, J.W.3    Ward, L.E.4
  • 204
    • 0028815763 scopus 로고
    • Sodium nitroprusside-induced delirium
    • Harmon C, Wohlreich MM. Sodium nitroprusside-induced delirium. Psychosomatics. 1995;36:83-85.
    • (1995) Psychosomatics , vol.36 , pp. 83-85
    • Harmon, C.1    Wohlreich, M.M.2
  • 205
    • 0023626057 scopus 로고
    • Visual hallucinations and suicidal ideation attributed to isosorbide dinitrate
    • Rosenthal R. Visual hallucinations and suicidal ideation attributed to isosorbide dinitrate. Psychosomatics. 1987;28:555-556.
    • (1987) Psychosomatics , vol.28 , pp. 555-556
    • Rosenthal, R.1
  • 206
    • 0016474953 scopus 로고
    • Hospital-acquired salicylate intoxication, report of a case with psychosis, acidosis, and coma
    • Good AE, Welch MH. Hospital-acquired salicylate intoxication, report of a case with psychosis, acidosis, and coma. J Rheumatol. 1975;2:52-60.
    • (1975) J Rheumatol , vol.2 , pp. 52-60
    • Good, A.E.1    Welch, M.H.2
  • 207
    • 34247234699 scopus 로고
    • Acute toxic psychosis due to acetyl-salicylic acid
    • Sawrer-Foner GJ, Morrison GH. Acute toxic psychosis due to acetyl-salicylic acid. Can Serv Med J. 1955;11:599-606.
    • (1955) Can Serv Med J , vol.11 , pp. 599-606
    • Sawrer-Foner, G.J.1    Morrison, G.H.2
  • 208
    • 0026478215 scopus 로고
    • Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it
    • Durnas C, Cusack BJ. Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it. Drugs Aging. 1992;2:20-34.
    • (1992) Drugs Aging , vol.2 , pp. 20-34
    • Durnas, C.1    Cusack, B.J.2
  • 209
    • 0242299634 scopus 로고    scopus 로고
    • Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE)
    • Nelson M, Reid C, Beilin L, et al. Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE). Drugs Aging. 2003;20:897-903.
    • (2003) Drugs Aging , vol.20 , pp. 897-903
    • Nelson, M.1    Reid, C.2    Beilin, L.3
  • 210
    • 0033788973 scopus 로고    scopus 로고
    • Perspectives in the treatment of vascular dementia
    • Roman G. Perspectives in the treatment of vascular dementia. Drugs Today (Barc). 2000;36:641-653.
    • (2000) Drugs Today (Barc) , vol.36 , pp. 641-653
    • Roman, G.1
  • 212
    • 0042913340 scopus 로고    scopus 로고
    • Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged > or =80 years
    • Nilsson SE, Johansson B, Takkinen S, et al. Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged > or =80 years. Eur J Clin Pharmacol. 2003;59:313-319.
    • (2003) Eur J Clin Pharmacol , vol.59 , pp. 313-319
    • Nilsson, S.E.1    Johansson, B.2    Takkinen, S.3
  • 213
    • 33646708039 scopus 로고    scopus 로고
    • Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: A pilot open-label study
    • Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello N. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol. 2006;21:227-231.
    • (2006) Int Clin Psychopharmacol , vol.21 , pp. 227-231
    • Mendlewicz, J.1    Kriwin, P.2    Oswald, P.3    Souery, D.4    Alboni, S.5    Brunello, N.6
  • 214
    • 0018426331 scopus 로고
    • Complications of disopyramide therapy
    • Nies AS, Gal J, Gerber JG. Complications of disopyramide therapy. Lancet. 1979;1:330-331.
    • (1979) Lancet , vol.1 , pp. 330-331
    • Nies, A.S.1    Gal, J.2    Gerber, J.G.3
  • 216
    • 0018693023 scopus 로고
    • Disopyramide-induced acute psychosis
    • Ahmad S, Sheikh AI, Meeran MK. Disopyramide-induced acute psychosis. Chest. 1979;76:712.
    • (1979) Chest , vol.76 , pp. 712
    • Ahmad, S.1    Sheikh, A.I.2    Meeran, M.K.3
  • 217
    • 0029126836 scopus 로고
    • The relationship between neurally mediated hypotension and the chronic fatigue syndrome
    • Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA. 1995;274:961-967.
    • (1995) JAMA , vol.274 , pp. 961-967
    • Bou-Holaigah, I.1    Rowe, P.C.2    Kan, J.3    Calkins, H.4
  • 218
    • 0028957255 scopus 로고
    • Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
    • Rowe PC, Bou-Holaigah I, Kan JS, Calkins H. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet. 1995;345:623-624.
    • (1995) Lancet , vol.345 , pp. 623-624
    • Rowe, P.C.1    Bou-Holaigah, I.2    Kan, J.S.3    Calkins, H.4
  • 219
    • 0032852738 scopus 로고    scopus 로고
    • Procainamide-induced psychosis: A case report and review of the literature
    • Bizjak ED, Nolan PE Jr, Brody EA, Galloway JM. Procainamide-induced psychosis: a case report and review of the literature. Ann Pharmacother. 1999;33:948-951.
    • (1999) Ann Pharmacother , vol.33 , pp. 948-951
    • Bizjak, E.D.1    Nolan Jr, P.E.2    Brody, E.A.3    Galloway, J.M.4
  • 220
    • 0027758084 scopus 로고
    • Procainamide-induced psychosis
    • Review
    • Harrington L. Procainamide-induced psychosis. Crit Care Nurse. 1993;13:70-72. Review.
    • (1993) Crit Care Nurse , vol.13 , pp. 70-72
    • Harrington, L.1
  • 221
    • 0021764617 scopus 로고
    • Psychosis induced by sustained-release procainamide
    • Schubert DS, Gabinet L, Hershey LA. Psychosis induced by sustained-release procainamide. Can Med Assoc J. 1984;131:1188-1190.
    • (1984) Can Med Assoc J , vol.131 , pp. 1188-1190
    • Schubert, D.S.1    Gabinet, L.2    Hershey, L.A.3
  • 222
    • 0018410419 scopus 로고
    • Procainamide-induced psychosis
    • Menken M. Procainamide-induced psychosis. JAMA. 1979;241:1107-1108.
    • (1979) JAMA , vol.241 , pp. 1107-1108
    • Menken, M.1
  • 223
    • 0018119893 scopus 로고
    • Procainamide-induced psychosis
    • McCrum ID, Guidry JR. Procainamide-induced psychosis. JAMA. 1978;240:1265-1266.
    • (1978) JAMA , vol.240 , pp. 1265-1266
    • McCrum, I.D.1    Guidry, J.R.2
  • 224
    • 0020032206 scopus 로고
    • Pharmacokinetics of a sustained release procainamide preparation
    • Flanagan AD. Pharmacokinetics of a sustained release procainamide preparation. Angiology. 1982;33:71-77.
    • (1982) Angiology , vol.33 , pp. 71-77
    • Flanagan, A.D.1
  • 225
  • 226
    • 17644414511 scopus 로고    scopus 로고
    • Drug-induced lupus
    • Rubin RL. Drug-induced lupus. Toxicology. 2005;209:135-147.
    • (2005) Toxicology , vol.209 , pp. 135-147
    • Rubin, R.L.1
  • 227
    • 0017528160 scopus 로고    scopus 로고
    • Cohen IS, Jick H, Cohen S1. Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug Surveillance Program. Prog Cardiovasc Dis. 1977;20:151-163.
    • Cohen IS, Jick H, Cohen S1. Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug Surveillance Program. Prog Cardiovasc Dis. 1977;20:151-163.
  • 228
    • 0026683154 scopus 로고
    • Cinchonism: Two case reports and review of acute quinine toxicity and treatment
    • Wolf LR, Otten EJ, Spadafora MP. Cinchonism: two case reports and review of acute quinine toxicity and treatment. J Emerg Med. 1992;10:295-301.
    • (1992) J Emerg Med , vol.10 , pp. 295-301
    • Wolf, L.R.1    Otten, E.J.2    Spadafora, M.P.3
  • 229
    • 0023658814 scopus 로고
    • Acute psychosis as idiosyncratic reaction to quinidine: Report of two cases
    • Deleu D, Schmedding E. Acute psychosis as idiosyncratic reaction to quinidine: report of two cases. BMJ (Clin Res Ed). 1987;294:1001-1002.
    • (1987) BMJ (Clin Res Ed) , vol.294 , pp. 1001-1002
    • Deleu, D.1    Schmedding, E.2
  • 230
    • 0025312537 scopus 로고
    • A functional psychosis precipitated by quinidine
    • Johnson AG, Day RO, Seldon WA. A functional psychosis precipitated by quinidine. Med J Aust. 1990;153:47-49.
    • (1990) Med J Aust , vol.153 , pp. 47-49
    • Johnson, A.G.1    Day, R.O.2    Seldon, W.A.3
  • 231
    • 0017821295 scopus 로고
    • Quinidine dementia
    • Gilbert GJ. Quinidine dementia. Am J Cardiol. 1978;41:791.
    • (1978) Am J Cardiol , vol.41 , pp. 791
    • Gilbert, G.J.1
  • 232
    • 0017756306 scopus 로고
    • Quinidine dementia
    • Gilbert GJ. Quinidine dementia. JAMA. 1977;237:2093-2094.
    • (1977) JAMA , vol.237 , pp. 2093-2094
    • Gilbert, G.J.1
  • 233
    • 0021868657 scopus 로고
    • Quinidine-induced organic mental disorders
    • Billig N, Buongiorno P. Quinidine-induced organic mental disorders. J Am Geriatr Soc. 1985;33:504-506.
    • (1985) J Am Geriatr Soc , vol.33 , pp. 504-506
    • Billig, N.1    Buongiorno, P.2
  • 234
    • 0019845155 scopus 로고
    • Neuropsychiatric sequelae of pharmacotherapy of cardiac arrhythmias and hypertension
    • Lloyd BL, Greenblatt DJ. Neuropsychiatric sequelae of pharmacotherapy of cardiac arrhythmias and hypertension. J Clin Psychopharmacol. 1981;1:394-398.
    • (1981) J Clin Psychopharmacol , vol.1 , pp. 394-398
    • Lloyd, B.L.1    Greenblatt, D.J.2
  • 236
    • 0030887422 scopus 로고    scopus 로고
    • Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain
    • Bennett MI. Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain. Pain. 1997;70:93-94.
    • (1997) Pain , vol.70 , pp. 93-94
    • Bennett, M.I.1
  • 237
    • 0022627113 scopus 로고
    • Dysarthria and visual hallucinations due to flecainide toxicity
    • Ramhamadany E, Mackenzie S, Ramsdale DR. Dysarthria and visual hallucinations due to flecainide toxicity. Postgrad Med J. 1986;62:61-62.
    • (1986) Postgrad Med J , vol.62 , pp. 61-62
    • Ramhamadany, E.1    Mackenzie, S.2    Ramsdale, D.R.3
  • 238
    • 0023836704 scopus 로고
    • Central nervous system side effects due to anti-arrhythmia therapy. Psychotic depression due to flecainide [in German]
    • Drerup U. Central nervous system side effects due to anti-arrhythmia therapy. Psychotic depression due to flecainide [in German]. Dtsch Med Wochenschr. 1988;113:386-388.
    • (1988) Dtsch Med Wochenschr , vol.113 , pp. 386-388
    • Drerup, U.1
  • 240
    • 0031734790 scopus 로고    scopus 로고
    • The thyroid axis and depression
    • Jackson IM. The thyroid axis and depression. Thyroid. 1998;8:951-956.
    • (1998) Thyroid , vol.8 , pp. 951-956
    • Jackson, I.M.1
  • 241
    • 0034084379 scopus 로고    scopus 로고
    • Psychoses associated with thyrotoxicosis - "thyrotoxic psychosis." A report of 18 cases, with statistical analysis of incidence
    • Brownlie BE, Rae AM, Walshe JW, Wells JE. Psychoses associated with thyrotoxicosis - "thyrotoxic psychosis." A report of 18 cases, with statistical analysis of incidence. Eur J Endocrinol. 2000;142:438-444.
    • (2000) Eur J Endocrinol , vol.142 , pp. 438-444
    • Brownlie, B.E.1    Rae, A.M.2    Walshe, J.W.3    Wells, J.E.4
  • 245
    • 0022595599 scopus 로고
    • High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias
    • Anastasiou-Nana MI, Anderson JL, Nanas JN, et al. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias. Can J Cardiol. 1986;2:138-145.
    • (1986) Can J Cardiol , vol.2 , pp. 138-145
    • Anastasiou-Nana, M.I.1    Anderson, J.L.2    Nanas, J.N.3
  • 246
    • 0032739882 scopus 로고    scopus 로고
    • More on amiodarone-induced depression
    • Odelola AT. More on amiodarone-induced depression. Br J Psychiatry. 1999;175:590-591.
    • (1999) Br J Psychiatry , vol.175 , pp. 590-591
    • Odelola, A.T.1
  • 247
    • 0032944571 scopus 로고    scopus 로고
    • Amiodarone-induced depression
    • Ambrose A, Salib E. Amiodarone-induced depression. Br J Psychiatry. 1999;174:366-367.
    • (1999) Br J Psychiatry , vol.174 , pp. 366-367
    • Ambrose, A.1    Salib, E.2
  • 249
    • 0028318526 scopus 로고
    • Neuropsychiatric adverse drug reactions: Passive reports to Health and Welfare Canada's adverse drug reaction database (1965-present)
    • Patten SB, Love EJ. Neuropsychiatric adverse drug reactions: passive reports to Health and Welfare Canada's adverse drug reaction database (1965-present). Int J Psychiatry Med. 1994;24:45-62.
    • (1994) Int J Psychiatry Med , vol.24 , pp. 45-62
    • Patten, S.B.1    Love, E.J.2
  • 250
    • 34247222780 scopus 로고    scopus 로고
    • Lanoxin (digoxin) prescribing information. Research Triangle Park, NC: GlaxoSmithKline; 2005.
    • Lanoxin (digoxin) prescribing information. Research Triangle Park, NC: GlaxoSmithKline; 2005.
  • 251
    • 0026246158 scopus 로고
    • Acute psychoses caused by digitalis poisoning [in Croatian]
    • Durakovic Z, Vucelic B, Plavsic F. Acute psychoses caused by digitalis poisoning [in Croatian]. Lijec Vjesn. 1991;113:417-419.
    • (1991) Lijec Vjesn , vol.113 , pp. 417-419
    • Durakovic, Z.1    Vucelic, B.2    Plavsic, F.3
  • 252
    • 0021885641 scopus 로고
    • Digoxin toxicity presenting with psychosis in a patient with chronic phobic anxiety
    • Carney MW, Rapp S, Pearce K. Digoxin toxicity presenting with psychosis in a patient with chronic phobic anxiety. Clin Neuropharmacol. 1985;8:193-195.
    • (1985) Clin Neuropharmacol , vol.8 , pp. 193-195
    • Carney, M.W.1    Rapp, S.2    Pearce, K.3
  • 253
    • 0017666512 scopus 로고
    • Psychosis: A rare manifestation of digoxin intoxication
    • Singh RB, Singh VP, Somani PN. Psychosis: a rare manifestation of digoxin intoxication. J Indian Med Assoc. 1977;69:62-63.
    • (1977) J Indian Med Assoc , vol.69 , pp. 62-63
    • Singh, R.B.1    Singh, V.P.2    Somani, P.N.3
  • 254
    • 0016733190 scopus 로고
    • Psychosis - a feature of digitalis intoxication
    • Gupta OP, Singh S, Gupta HM. Psychosis - a feature of digitalis intoxication. Indian Heart J. 1975;27:69-70.
    • (1975) Indian Heart J , vol.27 , pp. 69-70
    • Gupta, O.P.1    Singh, S.2    Gupta, H.M.3
  • 255
    • 0022627192 scopus 로고
    • Digitalis intoxication misdiagnosed as depression by primary care physicians
    • Wamboldt FS, Jefferson JW, Wamboldt MZ. Digitalis intoxication misdiagnosed as depression by primary care physicians. Am J Psychiatry. 1986;143:219-221.
    • (1986) Am J Psychiatry , vol.143 , pp. 219-221
    • Wamboldt, F.S.1    Jefferson, J.W.2    Wamboldt, M.Z.3
  • 256
    • 0034926650 scopus 로고    scopus 로고
    • Digitalis intoxication misdiagnosed as depression-revisited
    • Song YH, Terao T, Shiraishi Y, Nakamura J. Digitalis intoxication misdiagnosed as depression-revisited. Psychosomatics. 2001;42:369-370.
    • (2001) Psychosomatics , vol.42 , pp. 369-370
    • Song, Y.H.1    Terao, T.2    Shiraishi, Y.3    Nakamura, J.4
  • 258
    • 0035097378 scopus 로고    scopus 로고
    • Medication use and major depressive syndrome in a community population
    • Patten SB, Lavorato DH. Medication use and major depressive syndrome in a community population. Compr Psychiatry. 2001;42:124-131.
    • (2001) Compr Psychiatry , vol.42 , pp. 124-131
    • Patten, S.B.1    Lavorato, D.H.2
  • 259
    • 0029824487 scopus 로고    scopus 로고
    • Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population
    • Patten SB, Williams JV, Love EJ. Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population. Can J Psychiatry. 1996;41:469-476.
    • (1996) Can J Psychiatry , vol.41 , pp. 469-476
    • Patten, S.B.1    Williams, J.V.2    Love, E.J.3
  • 260
    • 34247243411 scopus 로고
    • Depressive and anxiety reactions treated with nicotinic acid and phenobarbital
    • Thompson LJ, Proctor RC. Depressive and anxiety reactions treated with nicotinic acid and phenobarbital. N C Med J. 1953;14:420-426.
    • (1953) N C Med J , vol.14 , pp. 420-426
    • Thompson, L.J.1    Proctor, R.C.2
  • 261
    • 34247206728 scopus 로고
    • Nicotinic acid in the treatment of depression
    • Tonge WL. Nicotinic acid in the treatment of depression. Ann Intern Med. 1953;38:551-553.
    • (1953) Ann Intern Med , vol.38 , pp. 551-553
    • Tonge, W.L.1
  • 262
    • 0012233207 scopus 로고
    • Massive niacin treatment in schizophrenia. Review of a nine-year study
    • Osmond H, Hoffer A. Massive niacin treatment in schizophrenia. Review of a nine-year study. Lancet. 1962;1:316-319.
    • (1962) Lancet , vol.1 , pp. 316-319
    • Osmond, H.1    Hoffer, A.2
  • 263
    • 0345782830 scopus 로고
    • Nicotinic acid: An adjunct in the treatment of schizophrenia
    • Hoffer A. Nicotinic acid: an adjunct in the treatment of schizophrenia. Am J Psychiatry. 1963;120:171-173.
    • (1963) Am J Psychiatry , vol.120 , pp. 171-173
    • Hoffer, A.1
  • 264
    • 0025809410 scopus 로고
    • Niacin and vitamin B6 in mental functioning: A review of controlled trials in humans
    • Kleijnen J, Knipschild P. Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans. Biol Psychiatry. 1991;29:931-941.
    • (1991) Biol Psychiatry , vol.29 , pp. 931-941
    • Kleijnen, J.1    Knipschild, P.2
  • 265
    • 0016295288 scopus 로고
    • Negative findings with nicotinic acid in the treatment of schizophrenias
    • Ban TA. Negative findings with nicotinic acid in the treatment of schizophrenias. Int Pharmacopsychiatry. 1974;9:172-187.
    • (1974) Int Pharmacopsychiatry , vol.9 , pp. 172-187
    • Ban, T.A.1
  • 266
    • 0021511255 scopus 로고
    • Cholestyramine induced hyperchloremic metabolic acidosis
    • Eaves ER, Korman MG. Cholestyramine induced hyperchloremic metabolic acidosis. Aust N Z J Med. 1984;14:670-672.
    • (1984) Aust N Z J Med , vol.14 , pp. 670-672
    • Eaves, E.R.1    Korman, M.G.2
  • 267
    • 0034304746 scopus 로고    scopus 로고
    • Worldwide Expanded Dose Simvastatin Study Group. Lipid-altering efficacy and safety of simvastatin 80 mg/day: Worldwide long-term experience in patients with hypercholesterolemia
    • Davidson MH, Stein EA, Hunninghake DB, et al. Worldwide Expanded Dose Simvastatin Study Group. Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia. Nutr Metab Cardiovasc Dis. 2000;10:253-2562.
    • (2000) Nutr Metab Cardiovasc Dis , vol.10 , pp. 253-2562
    • Davidson, M.H.1    Stein, E.A.2    Hunninghake, D.B.3
  • 268
    • 0034985133 scopus 로고    scopus 로고
    • STATT: A titrate-to-goal study of simvastatin in Asian patients with coronary heart disease. Simvastatin Treats Asians to Target
    • Chung N, Cho SY, Choi DH, et al. STATT: a titrate-to-goal study of simvastatin in Asian patients with coronary heart disease. Simvastatin Treats Asians to Target. Clin Ther. 2001;23:858-870.
    • (2001) Clin Ther , vol.23 , pp. 858-870
    • Chung, N.1    Cho, S.Y.2    Choi, D.H.3
  • 269
    • 0031580631 scopus 로고    scopus 로고
    • Statins-the pattern of adverse effects with empahsis on mental reactions. Data from a national and an international database [in Norwegian]
    • Buajordet I, Madsen S, Olsen H. Statins-the pattern of adverse effects with empahsis on mental reactions. Data from a national and an international database [in Norwegian], Tidsskr Nor Laegeforen .1997;117:3210-3213.
    • (1997) Tidsskr Nor Laegeforen , vol.117 , pp. 3210-3213
    • Buajordet, I.1    Madsen, S.2    Olsen, H.3
  • 273
    • 0026681128 scopus 로고
    • Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group
    • Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992;152:1490-1500.
    • (1992) Arch Intern Med , vol.152 , pp. 1490-1500
    • Neaton, J.D.1    Blackburn, H.2    Jacobs, D.3
  • 274
    • 0034127867 scopus 로고    scopus 로고
    • Grobbee. Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels
    • Steegmans PH, Hoes AW, Bak AA, van der Does E, Grobbee. Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels. Psychosom Med. 2000;62:205-211.
    • (2000) Psychosom Med , vol.62 , pp. 205-211
    • Steegmans, P.H.1    Hoes, A.W.2    Bak, A.A.3    van der Does, E.4
  • 275
    • 14644404915 scopus 로고    scopus 로고
    • Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission
    • Vevera J, Fisar Z, Kvasnicka T, et al. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res. 2005;133:197-203.
    • (2005) Psychiatry Res , vol.133 , pp. 197-203
    • Vevera, J.1    Fisar, Z.2    Kvasnicka, T.3
  • 276
    • 0042835785 scopus 로고    scopus 로고
    • Lipid-lowering drugs and the risk of depression and suicidal behavior
    • Yang CC, Jick SS, Jick H. Lipid-lowering drugs and the risk of depression and suicidal behavior. Arch Intern Med. 2003;163:1926-1932.
    • (2003) Arch Intern Med , vol.163 , pp. 1926-1932
    • Yang, C.C.1    Jick, S.S.2    Jick, H.3
  • 278
    • 0034645450 scopus 로고    scopus 로고
    • Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators
    • Stewart RA, Sharpies KJ, North FM, Menkes DB, Baker J, Simes J. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators. Arch Intern Med. 2000;160:3144-3152.
    • (2000) Arch Intern Med , vol.160 , pp. 3144-3152
    • Stewart, R.A.1    Sharpies, K.J.2    North, F.M.3    Menkes, D.B.4    Baker, J.5    Simes, J.6
  • 279
    • 0028181727 scopus 로고
    • Assessing possible hazards of reducing serum cholesterol
    • Law MR, Thompson SG, Wald NJ. Assessing possible hazards of reducing serum cholesterol. BMJ. 1994;308:373-379.
    • (1994) BMJ , vol.308 , pp. 373-379
    • Law, M.R.1    Thompson, S.G.2    Wald, N.J.3
  • 282
    • 0027514711 scopus 로고
    • Depressive symptoms and cholesterol-lowering drugs
    • Duits N, Bos FM. Depressive symptoms and cholesterol-lowering drugs. Lancet. 1993;341:114.
    • (1993) Lancet , vol.341 , pp. 114
    • Duits, N.1    Bos, F.M.2
  • 283
    • 0034015649 scopus 로고    scopus 로고
    • Effects of lovastatin on cognitive function and psychological well-being
    • Muldoon MF, Barger SD, Ryan CM, et al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med. 2000;108:538-546.
    • (2000) Am J Med , vol.108 , pp. 538-546
    • Muldoon, M.F.1    Barger, S.D.2    Ryan, C.M.3
  • 284
    • 0028603352 scopus 로고
    • Central nervous system effects of HMG CoA reductase inhibitors: Lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia
    • Kostis JB, Rosen RC, Wilson AC. Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia. J Clin Pharmacol. 1994;34:989-996.
    • (1994) J Clin Pharmacol , vol.34 , pp. 989-996
    • Kostis, J.B.1    Rosen, R.C.2    Wilson, A.C.3
  • 285
    • 0036121232 scopus 로고    scopus 로고
    • Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae
    • Paris D, Townsend KP, Humphrey J, Obregon DF, Yokota K, Mullan M. Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae. Atherosclerosis. 2002;161:293-239.
    • (2002) Atherosclerosis , vol.161 , pp. 293-239
    • Paris, D.1    Townsend, K.P.2    Humphrey, J.3    Obregon, D.F.4    Yokota, K.5    Mullan, M.6
  • 286
    • 20844440894 scopus 로고    scopus 로고
    • Atorvastatin for the treatment of mild to moderate Alzheimer disease: Preliminary results
    • Sparks DL, Sabbagh MN, Connor DJ, et al. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol. 2005;62:753-757.
    • (2005) Arch Neurol , vol.62 , pp. 753-757
    • Sparks, D.L.1    Sabbagh, M.N.2    Connor, D.J.3
  • 288
    • 22844431778 scopus 로고    scopus 로고
    • Statin use and the risk of incident dementia: The Cardiovascular Health Study
    • Rea TD, Breitner JC, Psaty BM, et al. Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol. 2005;62:1047-1051.
    • (2005) Arch Neurol , vol.62 , pp. 1047-1051
    • Rea, T.D.1    Breitner, J.C.2    Psaty, B.M.3
  • 289
    • 13244295723 scopus 로고    scopus 로고
    • Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study
    • Zandi PP, Sparks DL, Khachaturian AS, et al. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry. 2005;62:217-224.
    • (2005) Arch Gen Psychiatry , vol.62 , pp. 217-224
    • Zandi, P.P.1    Sparks, D.L.2    Khachaturian, A.S.3
  • 290
    • 0023811877 scopus 로고
    • HMG-CoA reductase inhibitors for hypercholesterolemia
    • Shaefer EJ. HMG-CoA reductase inhibitors for hypercholesterolemia. N Engl J Med. 1988;319:1222-1223.
    • (1988) N Engl J Med , vol.319 , pp. 1222-1223
    • Shaefer, E.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.